Press Releases

Friday, January 19, 2018

BUFFALO, N.Y. — The blood and marrow transplant (BMT) program at Roswell Park Comprehensive Cancer Center has been accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for the fifth consecutive time. The recognition reaffirms that the cancer center’s BMT program meets or exceeds the organization’s high standards for patient care and laboratory services.

New brand elements anchored around a key principle: ‘Unleashing the healing power of hope’
Tuesday, January 2, 2018

BUFFALO, N.Y. — Upstate New York’s only comprehensive cancer is marking its 120th anniversary with a fresh identity. Roswell Park Comprehensive Cancer Center is ushering in 2018 with a new name, mission and vision that are anchored around a central principle: “Unleashing the healing power of hope.”

Cancer center closes 2017 by attracting new leadership
Friday, December 29, 2017

BUFFALO, N.Y. — Seven senior employees are serving in new roles at Roswell Park Cancer Institute. While five of these program leaders were promoted or re-appointed, two have newly joined the Institute from other centers.

Wednesday, December 27, 2017

BUFFALO, N.Y. — Forty doctors at Roswell Park Cancer Institute are being recognized by Castle Connolly Medical Ltd. as America’s Top Doctors®.

Thursday, December 21, 2017

BUFFALO, N.Y. — Although men with prostate cancer usually respond to standard treatment with hormone therapy or chemotherapy, many will eventually experience progression or recurrence despite treatment — particularly those with high-risk or aggressive forms of the disease.

Tuesday, December 12, 2017
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, a research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute reports their discovery of a major mechanism by which cells regulate this important and multifunctional tumor suppressor, opening up new avenues for cancer research and treatment.
Monday, December 11, 2017
Experts from around the world who specialize in cancers of the blood, bone marrow and immune system are gathered in Atlanta, Georgia, for the 59th ASH Annual Meeting & Exposition, the annual meeting of the American Society of Hematology. Many Roswell Park Cancer Institute clinician-scientists are presenting new findings at the conference, including two whose research is being highlighted in podium presentations.
Tuesday, December 5, 2017
Fourteen promising preliminary cancer research projects at Roswell Park Cancer Institute recently received a total of $1,342,938 from the Roswell Park Alliance Foundation.
Friday, December 1, 2017
Roswell Park Cancer Institute’s 17th annual Tree of Hope lighting ceremony will draw cancer patients, survivors, caregivers and loved ones together for a holiday celebration Friday, Dec. 8, from 4:30 to 6:30 p.m. in Kaminski Park and Gardens on the Roswell Park campus. This free, family-friendly event will be held in honor of all who are touched by cancer. It will include live music, carriage rides, visits with Santa and Mrs. Claus, face painting and a gingerbread house raffle.
Tuesday, November 21, 2017
The first expert recommendations on recognition and clinical management of immune-related side effects from cancer immunotherapy are published today in the Journal for ImmunoTherapy of Cancer (JITC).
Friday, November 17, 2017

BUFFALO, N.Y. — In early 2018, SPoT Coffee will serve its first customer at a new location inside Roswell Park Cancer Institute.

Thursday, November 16, 2017
The Buffalo Sabres today announced that the team will again take part in the NHL Hockey Fights Cancer™ program, in partnership with the Courage of Carly Fund at Roswell Park Cancer Institute, during the team’s home game on Saturday, Nov. 18, at 7 p.m. against the Carolina Hurricanes.